Results 271 to 280 of about 46,488 (301)
Some of the next articles are maybe not open access.
Clinical Genetics, 1991
Immunochemical techniques have been used to identify five antigenic (Ag) sites on apolipoprotein B‐100 (apoB), the major protein constituent of very low density (VLDL), intermediate density (IDL), and low density lipoproteins (LDL). Each Ag site results from allelic variation at a specific locus of the apoB gene.
Miguel T. Robinson +2 more
openaire +3 more sources
Immunochemical techniques have been used to identify five antigenic (Ag) sites on apolipoprotein B‐100 (apoB), the major protein constituent of very low density (VLDL), intermediate density (IDL), and low density lipoproteins (LDL). Each Ag site results from allelic variation at a specific locus of the apoB gene.
Miguel T. Robinson +2 more
openaire +3 more sources
Klinische Wochenschrift, 1986
The main lipoprotein density classes, namely very-low-density lipoproteins (VLDL), intermediate-density lipoproteins (IDL), low-density lipoproteins (LDL), high-density lipoproteins2 (HDL2) and HDL3 were investigated with respect to their influence on hepatic lipase (HTGL) activity in vitro.
Ch. Breier +3 more
openaire +3 more sources
The main lipoprotein density classes, namely very-low-density lipoproteins (VLDL), intermediate-density lipoproteins (IDL), low-density lipoproteins (LDL), high-density lipoproteins2 (HDL2) and HDL3 were investigated with respect to their influence on hepatic lipase (HTGL) activity in vitro.
Ch. Breier +3 more
openaire +3 more sources
Clinical Biochemistry, 2014
Proprotein convertase subtilisin-kexin type 9 (PCSK9) is a key regulator of low density lipoprotein (LDL) receptor processing, but the PCSK9 pathway may also be implicated in the metabolism of triglyceride-rich lipoproteins. Here we determined the relationship of plasma PCSK9 with very low density lipoprotein (VLDL) and LDL subfractions.The ...
Kwakernaak, Arjan J. +2 more
openaire +6 more sources
Proprotein convertase subtilisin-kexin type 9 (PCSK9) is a key regulator of low density lipoprotein (LDL) receptor processing, but the PCSK9 pathway may also be implicated in the metabolism of triglyceride-rich lipoproteins. Here we determined the relationship of plasma PCSK9 with very low density lipoprotein (VLDL) and LDL subfractions.The ...
Kwakernaak, Arjan J. +2 more
openaire +6 more sources
Nephrology Dialysis Transplantation, 1992
The effect of bezafibrate, at doses of 200 mg three times weekly throughout a period of 10 weeks, on lipoprotein (a) and triglyceride-rich lipoproteins including intermediate-density lipoproteins (IDL) has been studied in 12 patients with chronic renal failure receiving haemodialysis.
Juan Rubiés-Prat +5 more
openaire +3 more sources
The effect of bezafibrate, at doses of 200 mg three times weekly throughout a period of 10 weeks, on lipoprotein (a) and triglyceride-rich lipoproteins including intermediate-density lipoproteins (IDL) has been studied in 12 patients with chronic renal failure receiving haemodialysis.
Juan Rubiés-Prat +5 more
openaire +3 more sources
Analytical Biochemistry, 1987
An exponential gradient gel with 0-10% acrylamide and 0.5% agarose was developed for electrophoresis of intact high molecular weight lipoproteins. This system resolves very low density lipoproteins, intermediate density lipoproteins, lipoprotein a, and low density lipoproteins in a size-dependent fashion.
Laurence Wong +4 more
openaire +3 more sources
An exponential gradient gel with 0-10% acrylamide and 0.5% agarose was developed for electrophoresis of intact high molecular weight lipoproteins. This system resolves very low density lipoproteins, intermediate density lipoproteins, lipoprotein a, and low density lipoproteins in a size-dependent fashion.
Laurence Wong +4 more
openaire +3 more sources
Clinica Chimica Acta, 2005
Intermediate-density lipoprotein (IDL) is a structurally related precursor of low-density lipoprotein (LDL). Although found in significantly lower levels, extensive evidence suggests that IDL shares LDL's capacity to promote atherosclerosis. To assist further investigation into IDL's composition and physiological relevance, we have established a rapid ...
McFarlane, Cheryl +4 more
openaire +3 more sources
Intermediate-density lipoprotein (IDL) is a structurally related precursor of low-density lipoprotein (LDL). Although found in significantly lower levels, extensive evidence suggests that IDL shares LDL's capacity to promote atherosclerosis. To assist further investigation into IDL's composition and physiological relevance, we have established a rapid ...
McFarlane, Cheryl +4 more
openaire +3 more sources
An intermediate density lipoprotein of rat serum
Archives of Biochemistry and Biophysics, 1969Melvin Fried +2 more
openaire +3 more sources